Company / SG&A per Share
Chemed Corp. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$28.85
FY2025
5-year range
$23.01 / $28.85
FY2021-FY2025
Trend
+3.2%
vs FY2024
Sector context
#11 of 157
Health Care
What the data says
Among 157 Health Care companies, Chemed Corp. is in the bottom 7% for sg&a per share. SG&A per Share has increased for 7 consecutive years, from $16.14 in FY2018 to $28.85 in FY2025.
Based on SEC 10-K filings.
28.85 in FY2025 with a 5-year CAGR of +7.5%. Top quartile in the Health Care sector.
Increased from $25.99 to $28.85 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +6.7%
- 5-Year CAGR
- +7.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 157This company $28.85 Sector average $11348.84
▼
-99.7% below sector average
Key checks
Key Insights
- Chemed Corp.'s sg&a per share has grown for 7 consecutive years.
- In FY2025, sg&a per share increased 3.2% year-over-year.
- Ranks #11 out of 157 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.85 | +3.2% |
| FY2024 | $27.94 | +7.5% |
| FY2023 | $25.99 | +9.4% |
| FY2022 | $23.76 | +3.3% |
| FY2021 | $23.01 | +14.3% |
| FY2020 | $20.14 | +8.9% |
| FY2019 | $18.50 | +14.6% |
| FY2018 | $16.14 | -2.3% |
| FY2017 | $16.52 | +13.9% |
| FY2016 | $14.51 | +6.3% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026